Mylan has issued a nationwide voluntary recall of injectable amiodarone, an antiarrhythmic for in-hospital use, that may have been mislabeled as tranexamic acid injection, according to the US Food and ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...

Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...

Aurobindo Pharma has received final approval from the USFDA to manufacture and market its Tranexamic acid injection, used for treating hemophilia, in the American market. The company plans to launch ...

Mylan NV announced that its US-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of amiodarone HCl injection, USP 450 mg/9 mL ...

Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...

Tranexamic Acid Injection is used in the treatment of short-term control of bleeding in hemophiliacs, including dental extraction procedures. This product is in the WHOs list of essential medicines.

(RTTNews) - Generic and specialty pharma company Mylan N.V. said its U.S.-based business Mylan Institutional LLC recalled four lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP ...

Represents the Company’s tenth product launch since inception in October 2023 SCHAUMBURG, Ill., June 24, 2024--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying ...